Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

NCT07237516 is registered in ClinicalTrials.gov with University of North Carolina, Chapel Hill as lead sponsor.

NCT NCT07237516
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07237516 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Lead sponsor
University of North Carolina, Chapel Hill
Phase
Observational
Overall status
Recruiting
Start date
November 20, 2025
Completion date
November 3, 2028
Enrollment
200 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease (cd), indeterminate colitis, inflammatory bowel disease (ibd), ulcerative colitis (uc)